ADIPOQ and obesity disorder: Low adiponectin concentrations and systemic low-grade inflammation have been suggested in the pathogenesis of several obesity-associated metabolic disorders in humans, including insulin resistance, hepatic steatosis, dyslipidemia, and atherosclerosis [4, 21, 22].